MediFind
Condition

Friedreich Ataxia

Active Clinical Trials

Clinical Trial
Dietary Supplement
  • Status: Recruiting
  • Study Type: Dietary Supplement
  • Participants: 72
  • Start Date: March 2, 2020
NAD+ Precursor Supplementation With Exercise Training to Increase Aerobic Capacity in Friedreich's Ataxia
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 120
  • Start Date: March 1, 2020
Characterization of the Interruptions of the GAA Expansion and Study of Their Influence on the Severity of Friedreich's Ataxia : INTREP-AF
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 144
  • Start Date: June 1, 2019
APDM Instrumented Data Exchange for Ataxia (IDEA) Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 40
  • Start Date: May 23, 2019
A Randomised Placebo-controlled Crossover Trial of Micronised Resveratrol as a Treatment for Friedreich Ataxia
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 70
  • Start Date: November 19, 2018
Effect of Nilotinib in Cerebellar Ataxia Patients
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 110
  • Start Date: November 20, 2017
Neurological Measures of Progression in Children With Friedrich Ataxia
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 203
  • Start Date: September 2015
Biomarkers in Friedreich's Ataxia
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 172
  • Start Date: January 2015
A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe)